Cargando…
Neuromuscular blocking agents for acute respiratory distress syndrome
Acute respiratory distress syndrome (ARDS) is an acute inflammatory process that impairs the ability of the lungs to oxygenate thereby resulting in respiratory failure. Treatment of ARDS is often a multimodal approach using both nonpharmacologic and pharmacologic treatment strategies in addition to...
Autores principales: | Torbic, Heather, Duggal, Abhijit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014082/ https://www.ncbi.nlm.nih.gov/pubmed/30396789 http://dx.doi.org/10.1016/j.jcrc.2018.10.019 |
Ejemplares similares
-
Neuromuscular blocking agents for acute respiratory distress syndrome: how did we get conflicting results?
por: Torbic, Heather, et al.
Publicado: (2019) -
Inhaled Prostacyclins for Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis
por: Torbic, Heather, et al.
Publicado: (2023) -
Recruitment manoeuvres for adults with acute respiratory distress syndrome receiving mechanical ventilation: a systematic review and meta-analysis
por: Kang, Hanyujie, et al.
Publicado: (2019) -
Factors associated with acute kidney injury in acute respiratory distress syndrome
por: Panitchote, Anupol, et al.
Publicado: (2019) -
Correction to: Factors associated with acute kidney injury in acute respiratory distress syndrome
por: Panitchote, Anupol, et al.
Publicado: (2019)